What Impact is Lead-Time Reduction Having on the End-to-End Pharma Supply Chain?




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: Antoine du Sartel, Director of Global Supply Chain at Merck Serono, speaks to Andrea charles from Pharma IQ, about the impact lead-time reduction is having on the end-to-end pharma supply chain and the steps we should take to ensure end-to-end supply chain optimisation. He